← All trials
NCT04140539
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 11, 2019
- Primary completion
- Aug 30, 2020
- Completion date
- Feb 28, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 3
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of California, Los AngelesLead sponsor
- Orchard Therapeutics LimitedStudy director
- Orchard Therapeutics LimitedOfficial
- University of California, Los AngelesSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.